Micromedic Technologies Ltd. logo

Micromedic Technologies Ltd.

Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics

1 employees · est. 1982 · Israel

VS
Nucleix Ltd. logo

Nucleix Ltd.

Developing cancer diagnostic panels based on epigenetic bio markers

72 employees · est. 2008 · Rehovot, Israel

Micromedic Technologies Ltd. is the older company (1982 vs 2008); Nucleix Ltd. is the larger of the two.

Side-by-Side Comparison

Micromedic Technologies Ltd. Nucleix Ltd.
Founded
1982 older 2008
Headquarters
Israel Rehovot, Israel
Employees
1 72 larger
Industry
Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Post Ipo Equity Unknown
Total Funding
$21.00M $82.25M
Funding Rounds
6 5
Services
Not tracked yet Development and Manufacturing of Non-Invasive Cancer Tests, Market Liquid Biopsy Assays, Research & Development in Cancer Detection, Collaboration with Leading Medical Institutions
Target Customers
Not tracked yet High-Risk Individuals for Early Lung Cancer Detection, Patients with Primary and Recurrent Bladder Cancer, Healthcare Providers and Medical Centers
Taxonomy
Cancer Diagnostics, In Vitro Diagnostics, CellDetect Technology, Bladder Cancer Test, Personalized Medicine, Early Cancer Detection, Pathology, Clinical Studies, Digital Pathology, Tumor Detection, Biopsy, Liquid-based Cytology, Morphological Examination, Color Discrimination, Innovation Cancer Diagnostics, Epigenetic Biomarkers, Liquid Biopsy, PCR-based Epigenetics, Methylation-based Identification, Non-invasive Testing, Bladder Cancer Detection, Lung Cancer Detection, Recurrent Cancer Monitoring, EpiCheck Platform, Medical Device CE-mark, FDA 510(k) Clearance, Urine-based Cancer Tests, Blood-based Cancer Tests, Molecular Diagnostic Tests
Website
m-medic.com nucleix.com
Micromedic Technologies Ltd. logo

About Micromedic Technologies Ltd.

Micromedic Technologies is a pioneering company in the field of in vitro cancer diagnostics. Founded in 1982 and headquartered in Israel, the company focuses on developing and commercializing cutting-edge diagnostic products and solutions for early cancer detection and personalized medicine. Their f...

Nucleix Ltd. logo

About Nucleix Ltd.

Nucleix Ltd., founded in 2008 and headquartered in Israel, is making significant strides in the biotechnology sector with its development of cancer diagnostic panels based on epigenetic biomarkers. Positioning itself at the forefront of innovation, Nucleix leverages PCR-based epigenetics to detect c...

We will tell you when either one moves

BounceWatch watches Micromedic Technologies Ltd. and Nucleix Ltd. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Micromedic Technologie... and Nucleix Ltd. — by email.

Frequently Asked Questions

Micromedic Technologies Ltd. — Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics. Nucleix Ltd. — Developing cancer diagnostic panels based on epigenetic bio markers. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Micromedic Technologies Ltd. has raised $21.00M while Nucleix Ltd. has raised $82.25M.
Micromedic Technologies Ltd. and Nucleix Ltd. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Micromedic Technologies Ltd. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Micromedic Technologies Ltd. on 12 Sep 2024, and Nucleix Ltd. on 22 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy